Ixekizumab
4 NDCs across 1 manufacturer|0 Generic,4 Brand
Ixekizumab is used to treat psoriasis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
In 2024, Medicare Part D spent $698 million on Ixekizumab across 85,000 claims for 14,000 beneficiaries.
Ixekizumab is available as 4 NDCs from 1 manufacturer (0 generic, 4 brand), with NADAC prices from $7373.54 to $7435.87 per ML — a 1% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
4
0G / 4B
Manufacturers
1
competing in market
Price Spread
$7373.54 – $7435.87
per ML
7d Activity
avg +0.0% WoW · of 4 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing IXEKIZUMAB
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
TALTZ 80 MG/ML AUTOINJECTOR (2-PACK) | $7435.8708 per ML | — |
TALTZ 80 MG/ML SYRINGE | $7402.0679 per ML | — |
TALTZ 80 MG/ML AUTOINJECTOR (3-PACK) | $7388.2220 per ML | — |
TALTZ 80 MG/ML AUTOINJECTOR | $7373.5427 per ML | +0.01% |
Frequently Asked Questions
What is Ixekizumab used to treat?
Ixekizumab is used to treat psoriasis, per the National Library of Medicine's MED-RT classification.
How much does Medicare spend on Ixekizumab?
In 2024, Medicare Part D spent $698 million on Ixekizumab across 85,000 claims for 14,000 beneficiaries.
How many Ixekizumab products are on the market?
The Ixekizumab drug market contains 4 NDCs from 1 manufacturer — 0 generic and 4 brand products.
What is the price range for Ixekizumab?
NADAC reference prices for Ixekizumab range from $7373.5427 to $7435.8708 per ML — a 1% difference between cheapest and most expensive.
Which manufacturers make Ixekizumab?
1 manufacturer lists Ixekizumab in NADAC. Ranked by number of NDCs, the largest are Eli Lilly and Company (4).
How has the price of Ixekizumab changed recently?
Over the past 7 days, 1 Ixekizumab NDC rose and 0 fell, with a market-wide average change of +0.0%.